Unveiling novel inhibitors of dopamine transporter via in silico drug design, molecular docking, and bioavailability predictions as potential antischizophrenic agents

by Sabitu Babatunde Olasupo, Adamu Uzairu, Gideon Adamu Shallangwa, Sani Uba
Published 2021-03-01

Structure-based design and activity modeling of novel epidermal growth factor receptor kinase inhibitors; an in silico approach

by Muhammad Tukur Ibrahim, Adamu Uzairu, Gideon Adamu Shallangwa, Sani Uba
Published 2020-09-01

Profiling the antidepressant properties of phenyl piperidine derivatives as inhibitors of serotonin transporter (SERT) via cheminformatics modeling, molecular docking and ADMET pre...

by Sabitu Babatunde Olasupo, Adamu Uzairu, Gideon Adamu Shallangwa, Sani Uba
Published 2020-09-01

Docking-based strategy to design novel flavone-based arylamides as potent V600E-BRAF inhibitors with prediction of their drug-likeness and ADMET properties

by Abdullahi Bello Umar, Adamu Uzairu, Gideon Adamu Shallangwa, Sani Uba
Published 2020-10-01

Chemoinformatic studies on some inhibitors of dopamine transporter and the receptor targeting schizophrenia for developing novel antipsychotic agents

by Sabitu Babatunde Olasupo, Adamu Uzairu, Gideon Adamu Shallangwa, Sani Uba
Published 2020-07-01

Computational virtual screening and structure-based design of some epidermal growth factor receptor inhibitors

by Muhammad Tukur Ibrahim, Adamu Uzairu, Sani Uba, Gideon Adamu Shallangwa
Published 2020-08-01

In silico evaluation of some 4-(quinolin-2-yl)pyrimidin-2-amine derivatives as potent V600E-BRAF inhibitors with pharmacokinetics ADMET and drug-likeness predictions

by Abdullahi Bello Umar, Adamu Uzairu, Gideon Adamu Shallangwa, Sani Uba
Published 2020-09-01

Quantitative structure-activity relationship, molecular docking, drug-likeness, and pharmacokinetic studies of some non-small cell lung cancer therapeutic agents

by Muhammad Tukur Ibrahim, Adamu Uzairu, Sani Uba, Gideon Adamu Shallangwa
Published 2020-12-01

Computational evaluation of potent 2-(1H-imidazol-2-yl) pyridine derivatives as potential V600E-BRAF inhibitors

by Abdullahi Bello Umar, Adamu Uzairu, Gideon Adamu Shallangwa, Sani Uba
Published 2020-11-01

Structure-based design of some quinazoline derivatives as epidermal growth factor receptor inhibitors

by Muhammad Tukur Ibrahim, Adamu Uzairu, Gideon Adamu Shallangwa, Sani Uba
Published 2020-11-01

Computer-aided identification of a series of novel ligands showing high potency as hepatitis C virus NS3/4A protease inhibitors

by Stephen Ejeh, Adamu Uzairu, Gideon Adamu Shallangwa, Stephen E. Abechi
Published 2021-01-01

COMPUTATIONAL STUDIES OF SOME BISCOUMARIN AND BISCOUMARIN THIOUREA DERIVATIVES AS ⍺-GLUCOSIDASE INHIBITORS

by Muhammad Tukur Ibrahim, Adamu Uzairu, Gideon Adamu Shallangwa, Abdulkadir Ibrahim
Published 2018-07-01

In-silico activity prediction and docking studies of some 2, 9-disubstituted 8-phenylthio/phenylsulfinyl-9h-purine derivatives as Anti-proliferative agents

by Muhammad Tukur Ibrahim, Adamu Uzairu, Gideon Adamu Shallangwa, Sani Uba
Published 2020-01-01

Computational modeling of novel quinazoline derivatives as potent epidermal growth factor receptor inhibitors

by Muhammad Tukur Ibrahim, Adamu Uzairu, Sani Uba, Gideon Adamu Shallangwa
Published 2020-02-01

Computer-aided molecular modeling studies of some 2, 3-dihydro-[1, 4] dioxino [2, 3-f] quinazoline derivatives as EGFRWT inhibitors

by Muhammad Tukur Ibrahim, Adamu Uzairu, Gideon Adamu Shallangwa, Sani Uba
Published 2020-04-01

QSAR modelling and molecular docking studies for anti-cancer compounds against melanoma cell line SK-MEL-2

by Abdullahi Bello Umar, Adamu Uzairu, Gideon Adamu Shallangwa, Sani Uba
Published 2020-03-01

In-silico studies of some oxadiazoles derivatives as anti-diabetic compounds

by Muhammad Tukur Ibrahim, Adamu Uzairu, Gideon Adamu Shallangwa, Abdulqadir Ibrahim
Published 2020-01-01

MOLECULAR DOCKING AND QUANTITATIVE STRUCTURE-ACTIVITY RELATIONSHIP (QSAR) STUDIES OF SOME SELECTED ANTI-ULCER INHIBITORS

by Muhammad Baba Muhammad, Adamu Uzairu, Gideon Adamu Shallangwa, Sani Uba
Published 2019-03-01

Molecular docking and QSAR theoretical model for prediction of phthalazinone derivatives as new class of potent dengue virus inhibitors

by Samuel Ndaghiya Adawara, Gideon Adamu Shallangwa, Paul Andrew Mamza, Abdulkadir Ibrahim
Published 2020-11-01

In-silico approaches towards the profiling of some anti-dengue virus as potent inhibitors against dengue NS-5 receptor

by Samuel Ndaghiya Adawara, Gideon Adamu Shallangwa, Paul Andrew Mamza, Abdulkadir Ibrahim
Published 2021-09-01